Galmed Pharmaceuticals secures South Korea patent for innovative liver disease combination therapy, extending global protection.
Jerusalem, 4 December, 2025 (TPS-IL) — Israeli biotech company Galmed Pharmaceuticals announced Thursday that South Korea has granted a new use patent for combining its lead drug candidate, Aramchol, with Rezdiffra, developed by U.S.-based Madrigal Pharmaceuticals, for treating liver fibrosis and MASH, a progressive liver disease.
The Ramat Gan–based firm said the patent extends Aramchol’s global protection to July 2042, adding to existing patents in the U.S., Europe and Canada.
Real-time breaking news coverage from Israel and the Middle East. Stay informed with the latest developments as they happen.
Israel Police arrested suspects after a pursuit with gunfire in Jericho, who endangered road users and injured officers.
IDF launches targeted strikes in southern Lebanon following Hezbollah's blatant violation.
Israel Police investigate a body found washed ashore near Zichron Yaakov, securing the scene and initiating identification efforts.
Herzliya police investigate explosion near business; no damage or casualties reported; incident believed to be criminal.
Roads 1 and 6 near Ben Shemen are now open after a fire; police manage traffic, expect delays, and advise alternative routes.
Jerusalem Police conclude investigation into Benyahu Raz's murder, filing charges against seven suspects for their involvement in the violent incident.
Home of terrorist in Tel village shooting attack, where two soldiers fell, ordered confiscated and demolished by Central Command.
Israel Police thwarted a smuggling cell on the western border, arresting two suspects and seizing a drone, ATV, and drugs.
IDF and Shin Bet eliminate Hamas Nukhba commander Jalal Tsvih responsible for October 7th massacre.
Shortly ago, a report was received about a shooting victim in Kafr Qasim.